Literature DB >> 9638401

Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease.

D H Van Thiel1, L Friedlander, N De Maria, P J Molloy, R J Kania, A Colantoni.   

Abstract

The problems associated with the recognition and management of chronic hepatitis C in a population of individuals with confounding psychiatric disease are identified. The experience of treating such patients and the psychotropic medication required during treatment are reviewed.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9638401

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN： 0172-6390


  7 in total

1.  Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Authors:  B R Edlin; K H Seal; J Lorvick; A H Kral; D H Ciccarone; L D Moore; B Lo
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

2.  In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450.

Authors:  Tami Pilot-Matias; Rakesh Tripathi; Daniel Cohen; Isabelle Gaultier; Tatyana Dekhtyar; Liangjun Lu; Thomas Reisch; Michelle Irvin; Todd Hopkins; Ron Pithawalla; Timothy Middleton; Teresa Ng; Keith McDaniel; Yat Sun Or; Rajeev Menon; Dale Kempf; Akhteruzzaman Molla; Christine Collins
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

3.  Validation of the FACT-BRM with interferon-alpha treated melanoma patients.

Authors:  Amber G Paterson; Peter C Trask; Lynne I Wagner; Peg Esper; Bruce Redman
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

Review 4.  Neuropsychiatric adverse effects of interferon-alpha: recognition and management.

Authors:  Charles L Raison; Marina Demetrashvili; Lucile Capuron; Andrew H Miller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

6.  Hepatitis B and C among veterans on a psychiatric ward.

Authors:  James H Tabibian; Donna A Wirshing; Joseph M Pierre; Lisa H Guzik; Michael D Kisicki; Itai Danovitch; Shirley J Mena; William C Wirshing
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

7.  Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C).

Authors:  Aybike Birerdinc; Arian Afendy; Maria Stepanova; Issah Younossi; Ancha Baranova; Zobair M Younossi
Journal:  Brain Behav       Date:  2012-07-06       Impact factor: 2.708
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.